Saroja Pharma Industries India Ltd
Saroja Pharma Industries India Ltd Share Price Today: Live Updates & Key Insights
Get insights on Saroja Pharma Industries India Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Saroja Pharma Industries India Ltd Share Price Chart
Saroja Pharma Industries India Ltd Fundamentals
Traded Volume: 1,600
Market Cap(Cr): 17
Avg Traded Price 49.78
1 Year return %
Upper Circuit 43.1
Lower Circuit 43.1
P/E TTM 20.00
P/B Ratio 2.00
Traded Value(Cr) 0.69
EPS TTM 2.185
Book value 2.185
Dividend 0.00%
Saroja Pharma Industries India Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Saroja Pharma Industries India Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Saroja Pharma Industries India Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -3.03%
1M -4.11%
3M +20.53%
1Y null%
YTD -26.76%
Saroja Pharma Industries India Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Saroja Pharma Industries India Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 3200.00
Day Before Yesterday 1600.00
1W Avg null
1M Avg 3911.11
3M Avg 14635.29
Saroja Pharma Industries India Ltd Technical Details
Saroja Pharma Industries India Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 43
Support 2 43
Support 3 43
Pivot Point : 43
Resistance 1 43
Resistance 2 43
Resistance 3 43
Saroja Pharma Industries India Ltd Corporate Actions
Saroja Pharma Industries India Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Saroja Pharma Industries India Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by SAROJA
Bonus
No Bonus has been declared by SAROJA
Splits
No Split has been declared by SAROJA
Others
Rights No Rights has been declared by SAROJA
Saroja Pharma Industries India Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Saroja Pharma Industries India Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Saroja Pharma Industries India Ltd's relative performance and valuation against major competitors.
Stock Name Machhar Industries Ltd ₹317.50 (+0.63%) M. Cap (Cr) 0.24 1 Yr Return (%) -23.49% P/E (TTM) 184.79 PB Ratio 1.93
Stock Name Caprolactam Chemicals Ltd ₹48.81 (+4.01%) M. Cap (Cr) 0.22 1 Yr Return (%) -7.45% P/E (TTM) -279.44 PB Ratio 4.65
Stock Name Harmony Capital Services Ltd ₹69.57 (0.00%) M. Cap (Cr) 0.21 1 Yr Return (%) +16.34% P/E (TTM) -57.47 PB Ratio 28.34
Stock Name Saroja Pharma Industries India Ltd ₹43.15 (+1.05%) M. Cap (Cr) 0.17 1 Yr Return (%) NaN% P/E (TTM) 19.75 PB Ratio 1.18
Stock Name Chemiesynth (Vapi) Ltd ₹37.63 (+4.99%) M. Cap (Cr) 0.12 1 Yr Return (%) NaN% P/E (TTM) -36.21 PB Ratio 1.05
Stock Name Omkar Speciality Chemicals Ltd ₹5.26 (-1.31%) M. Cap (Cr) 0.11 1 Yr Return (%) -48.13% P/E (TTM) -0.82 PB Ratio -0.06
Stock Name Pratiksha Chemicals Ltd ₹19.19 (-6.39%) M. Cap (Cr) 0.11 1 Yr Return (%) -15.09% P/E (TTM) -3.56 PB Ratio -2.65
Saroja Pharma Industries India Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Saroja Pharma Industries India Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2024 1.02 Mar 2023 2.19 Mar 2022 -3.67 Mar 2021 -1.09 Mar 2020 -0.89
PARTICULARS Investing Activities Mar 2024 -4.76 Mar 2023 -4.82 Mar 2022 -0.34 Mar 2021 -0.05 Mar 2020 -0.02
PARTICULARS Financing Activities Mar 2024 3.70 Mar 2023 2.73 Mar 2022 4.27 Mar 2021 1.06 Mar 2020 0.97
PARTICULARS Net Cash Flow Mar 2024 -0.04 Mar 2023 0.10 Mar 2022 0.26 Mar 2021 -0.07 Mar 2020 0.06
Saroja Pharma Industries India Ltd Shareholding Pattern
This shows the ownership breakdown of Saroja Pharma Industries India Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 73.02%
Public 26.99%
Other Institutions 0%
FII null%
Mutual Funds null%
About Saroja Pharma Industries India Ltd
Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of "Saroja Pharma Industries India Private Limited" on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra. Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to "Saroja Pharma Industries India Limited" through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name "Saroja Pharma Industries India Private Limited." During this time, they focused on building a strong foundation and laying the groundwork for their future growth and success. With dedication and strategic planning, they managed to establish a reputable presence in the pharmaceutical industry. Gradually, as Company expanded and gained momentum, the Promoters made a significant decision to convert their business from a Private Limited to a Public Limited, through which the Company was establish. Thus, transformation opened up new avenues for growth, allowing it to access a wider pool of investors and enhance the overall market presence. With the new status as a Public Limited Company, Saroja Pharma Industries India Limited further strengthen position into pharmaceutical and healthcare sectors. Thereafter, the Promoters envisioned leveraging the Company`s expanded resources, increased capital formation, and enhanced market reach. Under the leadership of Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, Company continues for excellence, innovation, and global integration. Their commitment in providing high-quality pharmaceutical and healthcare products has helped it earn recognition and trust from both domestic and international customers. With a customer-centric approach and a focus on industry-leading practices, Company is poised to make a significant impact in the global healthcare landscape. Since established, the Company provide service deliverance in chemical trading with the best premium pharmaceutical companies in India and abroad for cost effective human and veterinary medicine. Presently, the Company trade into Active Pharmaceuticals Ingredients (API), Pharma Intermediates, Specialty Chemicals, Intermediates for Pharma trading and Solvents used for pharmaceutical products in human and veterinary medicine. The product demand by their clientele is manufactured as per their specifications by suppliers initially in sample size thereafter on clients testing and approving the order is finalized. The approved specified product is manufactured for the order quantity to be dispatched by the appropriate mode of transport within India or abroad. Prior to this, the Company witnessed a substantial expansion in its clientele base over the past two years. This growth has propelled the Company to venture into the manufacturing of API Pharma products, in making cost-effective contributions to human and veterinary medicine. The Company is planning for a Public Issue of 10,84,800 Equity shares aggregating to Rs 9.11 Crores by raising capital through Fresh Issue.
Chairman & Managing Director
Biju Gopinathan Nair
Registered office 305 Kailash Tower Shiv Shristi, Complex Goregaon Link Rd Mum-W, Mumbai, Maharashtra, 400080
FAX :+91 022 2081 0011
Background
Incorporation Year 2019
Face Value ₹10.00
Market Lot 1600
FAQs on Saroja Pharma Industries India Ltd
How to buy Saroja Pharma Industries India Ltd shares on NSE?
To buy Saroja Pharma Industries India Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Saroja Pharma Industries India Ltd share price today?
The Saroja Pharma Industries India Ltd share price on NSE is ₹43.15 today.
What is the market cap of Saroja Pharma Industries India Ltd on NSE?
The company has a market capitalization of ₹17.35.
What is the PE & PB ratio of Saroja Pharma Industries India Ltd?
PE is 20 and PB is 2.
What is the 52 Week High and Low of Saroja Pharma Industries India Ltd shares?
Saroja Pharma Industries India Ltd stock price high: ₹61.95 Saroja Pharma Industries India Ltd stock price low: ₹34.